| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| INTLI - Finanziamenti internazionali |
Targeting Drp1 activation and mitochondrial Fission tO Curtail muscle wasting during Duchenne MUscular DyStrophy progression (FOCUS)
|
|
Ongoing | 2022 |
| AL_RIC - Bandi da altri enti di ricerca |
Validazione di due nuovi trattamenti per la sindrome di Rett: focus sui difetti respiratori della malattia
|
|
Ongoing | 2022 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV
|
|
Ongoing | 2022 |
| PRIN2022 - PRIN bando 2022 |
Elucidating the role of the lysosomal impairment in neurodegeneration: metabolic implications and consequences of lysosomal exocytosis on the propagation of neuronal damage
|
|
Ongoing | 2023 |
| INTLI - Finanziamenti internazionali |
The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
The natural antisense lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (3° anno)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
All-optical fingerprinting of metastatic potential (5° anno)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Functional study on a new pharmacological approach in the Rett Syndrome
|
|
Ongoing | 2023 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2022)
|
|
Ongoing | 2023 |
